ARTICLE IN ACADEMIC JOURNALS
| NO | DETAILS OF ARTICLE IN ACADEMIC JOURNALS |
|---|---|
| 1. |
Personalised learning in higher education for health sciences: a scoping review protocol
2024
Author(s) : Hasniza Binti Zaman Huri, Izyan Binti A Wahab Source :
SYSTEMATIC REVIEWS
DOI :
10.1186/s13643-024-02478-4
|
| 2. |
Ethnic disparities and its association between epicardial adipose tissue thickness and cardiometabolic parameters
2024
Author(s) : Hasniza Binti Zaman Huri, Ahmad Syadi Bin Mahmood Zuhdi, Amira Hajirah Bt Abd Jamil, Kayatri A/p Govindaraju Source :
ADIPOCYTE
DOI :
10.1080/21623945.2024.2314032
|
| 3. |
The impact of perceived vaginal and urinary symptoms and treatment burden in predicting sexual functioning among perimenopausal and postmenopausal women
2024
Author(s) : Hasniza Binti Zaman Huri Source :
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
DOI :
10.1002/ijgo.15736
|
| 4. |
Association of the Reduced Function Met420del Polymorphism of SLC22A1 with Metformin-Induced Gastrointestinal Intolerance in Ethiopian Patients with Type 2 Diabetes Mellitus
2024
Author(s) : Hasniza Binti Zaman Huri, Sim Maw Shin Source :
PHARMACOGENOMICS & PERSONALIZED MEDICINE
DOI :
10.2147/PGPM.S457374
|
| 5. |
The effects of SGLT-2 inhibitor on epicardial adipose tissue (EAT) thickness in general cardiology admission patient
2023
Author(s) : Hasniza Binti Zaman Huri, Ahmad Syadi Bin Mahmood Zuhdi Source :
INTERNATIONAL JOURNAL OF CARDIOLOGY
DOI :
10.1016/j.ijcard.2023.131519
|
| 6. |
The associations of cardiac functions with glycaemic control parameters in type 2 diabetic (T2DM) patients with coronary artery disease (CAD) following sodium-glucose cotransporter-2 (SGLT-2) inhibitors: A preliminary quasi-experimental cohort analysis
2023
Source :
INTERNATIONAL JOURNAL OF CARDIOLOGY
DOI :
10.1016/j.ijcard.2023.131487
|
| 7. |
Association of Met420del Variant of Metformin Transporter Gene SLC22A1 with Metformin Treatment Response in Ethiopian Patients with Type 2 Diabetes
2023
Author(s) : Sim Maw Shin, Hasniza Binti Zaman Huri Source :
Diabetes Metabolic Syndrome and Obesity-Target & Therapy
DOI :
10.2147/DMSO.S426632
|
| 8. |
Angiotensin converting enzyme (ACE) inhibitors activity from purified compounds Fructus Phaleria macrocarpa (Scheff) Boerl
2023
Author(s) : Hasniza Binti Zaman Huri Source :
BMC COMPLEMENTARY MEDICINE AND THERAPIES
DOI :
10.1186/s12906-023-03889-x
|
| 9. |
Precision Medicine in Erythropoietin Deficiency and Treatment Resistance: A Novel Approach to Management of Anaemia in Chronic Kidney Disease
2023
Author(s) : Hasniza Binti Zaman Huri, Lim Soo Kun Source :
CURRENT ISSUES IN MOLECULAR BIOLOGY
DOI :
10.3390/cimb45080413
|
| 10. |
Development and validation of the genitourinary syndrome of menopause symptoms and vaginal treatments acceptability questionnaire (GSM-SVTAQ): An electronic patient-reported outcomes measure
2023
Author(s) : Hasniza Binti Zaman Huri Source :
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
DOI :
10.1002/ijgo.15106
|
| 11. |
Determinants and Effects of Vitamin D Supplementation in Postmenopausal Women: A Systematic Review
2023
Author(s) : Hasniza Binti Zaman Huri Source :
NUTRIENTS
DOI :
10.3390/nu15030685
|
| 12. |
Therapeutic Effects of Vitamin D on Vaginal, Sexual, and Urological Functions in Postmenopausal Women
2023
Author(s) : Hasniza Binti Zaman Huri Source :
NUTRIENTS
DOI :
10.3390/nu15173804
|
| 13. |
Antidepressant decision aid for major depressive disorder patients (ADAM): Development and pilot testing (vol 105, pg 2466, 2022)
2023
Source :
PATIENT EDUCATION AND COUNSELING
DOI :
10.1016/j.pec.2023.107852
|
| 14. |
Potential immunological and genetic markers associated with lupus nephritis: From pathogenicity to therapeutic drug target
2023
Source :
AUTOIMMUNITY REVIEWS
DOI :
10.1016/j.autrev.2023.103406
|
| 15. |
Potential immunological and genetic markers associated with lupus nephritis: From pathogenicity to therapeutic drug target
2023
Source :
AUTOIMMUNITY REVIEWS
DOI :
10.1016/j.autrev.2023.103406
|
| 16. |
Genetic Markers of Insulin Resistance and Atherosclerosis in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease
2023
Author(s) : Shireene Ratna A/p D B Vethakkan, Hasniza Binti Zaman Huri Source :
METABOLITES
DOI :
10.3390/metabo13030427
|
| 17. |
Adherence tool for prophylactic haemophilia treatment in adult and adolescent patients: A systematic review and meta-analysis protocol
2023
Author(s) : Hasniza Binti Zaman Huri Source :
PLOS ONE
DOI :
10.1371/journal.pone.0289815
|
| 18. |
Antidepressant decision aid for major depressive disorder patients (ADAM): Development and pilot testing
2022
Author(s) : Ahmad Hatim Bin Sulaiman, Hasniza Binti Zaman Huri, Aya Ahmed Abousheishaa Mohamed Khalil Source :
Patient Education and Counseling
DOI :
10.1016/j.pec.2021.11.007
|
| 19. |
Pharmacokinetic-Pharmacometabolomic Approach in Early-Phase Clinical Trials: A Way Forward for Targeted Therapy in Type 2 Diabetes
2022
Source :
PHARMACEUTICS
DOI :
10.3390/pharmaceutics14061268
|
| 20. |
Targeted Primary and Secondary Preventive Strategies for Depression among Malaysian Pharmacy Students
2022
Author(s) : Hasniza Binti Zaman Huri, Izyan Binti A Wahab Source :
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
DOI :
10.3390/ijerph19159629
|
| 21. |
Antidepressant decision aid for major depressive disorder patients (ADAM): Development and pilot testing
2022
Author(s) : Ahmad Hatim Bin Sulaiman, Hasniza Binti Zaman Huri, Aya Ahmed Abousheishaa Mohamed Khalil Source :
PATIENT EDUCATION AND COUNSELING
DOI :
10.1016/j.pec.2021.11.007
|
| 22. |
Pharmacokinetics and Metabolomic Profiling of Metformin and Andrographis paniculata: A Protocol for a Crossover Randomised Controlled Trial
2022
Source :
JOURNAL OF CLINICAL MEDICINE
DOI :
10.3390/jcm11143931
|
| 23. |
Insulin therapy associated with deterioration in left ventricular ejection fraction in heart failure patients with type 2 diabetes
2022
Author(s) : Hasniza Binti Zaman Huri Source :
INTERNATIONAL JOURNAL OF CARDIOLOGY
DOI :
10.1016/j.ijcard.2022.10.082
|
| 24. |
Psychiatric pharmaceutical care service across Malaysian hospitals: results from a cross-sectional study
2022
Author(s) : Ahmad Hatim Bin Sulaiman, Noorasyikin Binti Shamsuddin, Hasniza Binti Zaman Huri, Aya Ahmed Abousheishaa Mohamed Khalil Source :
BMC health services research
DOI :
10.1186/s12913-022-07681-4
|
| 25. |
Pharmacokinetic–Pharmacometabolomic Approach in Early-Phase Clinical Trials: A Way Forward for Targeted Therapy in Type 2 Diabetes
2022
Source :
Pharmaceutics
DOI :
10.3390/pharmaceutics14061268
|
| 26. |
Psychiatric pharmaceutical care service across Malaysian hospitals: results from a cross-sectional study
2022
Author(s) : Ahmad Hatim Bin Sulaiman, Noorasyikin Binti Shamsuddin, Hasniza Binti Zaman Huri, Aya Ahmed Abousheishaa Mohamed Khalil Source :
BMC HEALTH SERVICES RESEARCH
DOI :
10.1186/s12913-022-07681-4
|
| 27. |
Pharmacokinetics and Metabolomic Profiling of Metformin and Andrographis paniculata: A Protocol for a Crossover Randomised Controlled Trial
2022
Source :
Journal of Clinical Medicine
DOI :
10.3390/jcm11143931
|
| 28. |
Targeted Primary and Secondary Preventive Strategies for Depression among Malaysian Pharmacy Students
2022
Author(s) : Hasniza Binti Zaman Huri, Izyan Binti A Wahab Source :
International journal of environmental research and public health
DOI :
10.3390/ijerph19159629
|
| 29. |
Pharmacogenetics of sulfonylurea-induced hypoglycemia in Type 2 diabetes patients: the SUCLINGEN study
2021
Author(s) : Shireene Ratna A/p D B Vethakkan, Hasniza Binti Zaman Huri Source :
PHARMACOGENOMICS
DOI :
10.2217/pgs-2021-0059
|
| 30. |
Associations between Socio-Demographic Factors and Hypertension Management during the COVID-19 Pandemic: Preliminary Findings from Malaysia
2021
Author(s) : Hasniza Binti Zaman Huri Source :
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
DOI :
10.3390/ijerph18179306
|
| 31. |
Single Nucleotide Polymorphism rs17173608 in the Chemerin Encoding Gene: Is It a Predictor of Insulin Resistance and Severity of Coronary Artery Disease in Non-Obese Type 2 Diabetes?
2021
Author(s) : Wan Azman Bin Wan Ahmad, Hasniza Binti Zaman Huri Source :
HEALTHCARE
DOI :
10.3390/healthcare9060623
|
| 32. |
Retinol-Binding Protein-4-A Predictor of Insulin Resistance and the Severity of Coronary Artery Disease in Type 2 Diabetes Patients with Coronary Artery Disease
2021
Author(s) : Wan Azman Bin Wan Ahmad, Hasniza Binti Zaman Huri Source :
BIOLOGY-BASEL
DOI :
10.3390/biology10090858
|
| 33. |
Patient-Centred Communication in the Use of Antidepressants among People with Depression: A Scoping Review
2021
Author(s) : Ahmad Hatim Bin Sulaiman, Jesjeet Singh Gill A/l Jeswant Singh, Hasniza Binti Zaman Huri, Koh Ong Hui, Ng Chong Guan, Fatin Liyana Binti Azhar, Benedict Francis Source :
SAINS MALAYSIANA
DOI :
10.17576/jsm-2021-5001-16
|
| 34. |
A Clinical Practice Guideline Summary for Pharmacological Management of Adults with Major Depressive Disorder in Malaysia
2021
Author(s) : Ahmad Hatim Bin Sulaiman, Hasniza Binti Zaman Huri, Ng Chong Guan, Aya Ahmed Abousheishaa Mohamed Khalil Source :
JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL
DOI :
10.9734/JPRI/2021/v33i45B32821
|
| 35. |
Association of YKL-40 Encoding Gene CHI3L1 rs946263 with Insulin Resistance and Severity of Coronary Artery Disease in Type 2 Diabetes Mellitus Patients
2021
Author(s) : Hasniza Binti Zaman Huri Source :
METABOLISM-CLINICAL AND EXPERIMENTAL
DOI :
10.1016/j.metabol.2020.154520
|
| 36. |
Pharmacometabolomics of Meformin Demonstrated Insulin Sensitivity Related Pathways at Peak Plasma Concentration on Healthy Volunteers - Preliminary Results
2021
Source :
METABOLISM-CLINICAL AND EXPERIMENTAL
DOI :
10.1016/j.metabol.2020.154536
|
| 37. |
Medication Adherence for Haemophilia Patients: Outcome of Prophylaxis Treatment Intervention
2021
Author(s) : Hasniza Binti Zaman Huri Source :
HEALTHCARE
DOI :
10.3390/healthcare9121702
|
| 38. |
GLOBAL SCOPE OF HOSPITAL PHARMACY PRACTICE: A SCOPING REVIEW
2020
Author(s) : Hasniza Binti Zaman Huri Source :
Healthcare
|
| 39. |
Clinical and genetic markers of erythropoietin deficiency anemia in chronic kidney disease (predialysis) patients
2020
Author(s) : Hasniza Binti Zaman Huri, Lim Soo Kun Source :
BIOMARKERS IN MEDICINE
DOI :
10.2217/bmm-2020-0205
|
| 40. |
Clinical and genetic predictors of secondary sulfonylurea failure in Type 2 diabetes patients: the SUCLINGEN study
2020
Author(s) : Shireene Ratna A/p D B Vethakkan, Hasniza Binti Zaman Huri Source :
PHARMACOGENOMICS
DOI :
10.2217/pgs-2019-0171
|
| 41. |
Heart Failure with Type 2 Diabetes Mellitus: Association between Antihyperglycemic Agents, Glycemic Control, and Ejection Fraction
2020
Author(s) : Hasniza Binti Zaman Huri, Chee Kok Han Source :
Frontiers in Endocrinology
|
| 42. |
Clinical and genetic predictors of secondary sulfonylurea failure in type 2 diabetes patients: The SUCLINGEN study
2020
Author(s) : Hasniza Binti Zaman Huri, Shireene Ratna A/p D B Vethakkan Source :
Pharmacogenomics
|
| 43. |
Heart Failure With Type 2 Diabetes Mellitus: Association Between Antihyperglycemic Agents, Glycemic Control, and Ejection Fraction
2020
Author(s) : Hasniza Binti Zaman Huri, Chee Kok Han Source :
FRONTIERS IN ENDOCRINOLOGY
DOI :
10.3389/fendo.2020.00448
|
| 44. |
Global Scope of Hospital Pharmacy Practice: A Scoping Review
2020
Author(s) : Ahmad Hatim Bin Sulaiman, Hasniza Binti Zaman Huri, Ng Chong Guan, Aya Ahmed Abousheishaa Mohamed Khalil Source :
HEALTHCARE
DOI :
10.3390/healthcare8020143
|
| 45. |
Clinical and Genetic Marker of Erythropoietin Deficiency Anaemia in Chronic Kidney Disease (pre-dialysis) Patients
2020
Author(s) : Hasniza Binti Zaman Huri Source :
Biomarkers in Medicine
|
| 46. |
Drug-related problems in patients with rheumatoid arthritis
2019
Author(s) : Hasniza Binti Zaman Huri, Fariz Bin Yahya Source :
THERAPEUTICS AND CLINICAL RISK MANAGEMENT
DOI :
10.2147/TCRM.S194921
|
| 47. |
Pharmacist-led Academic Detailing Improves Statin Therapy Prescribing for Malaysian Patients with Type 2 Diabetes: Quasi-Experimental Design
2019
Author(s) : Hasniza Binti Zaman Huri Source :
Plos One
|
| 48. |
Drug-related problems in patients with rheumatoid arthritis.
2019
Author(s) : Fariz Bin Yahya, Hasniza Binti Zaman Huri Source :
Therapeutics and Clinical Risk Management
|
| 49. |
Effectiveness and prescription pattern of lipid-lowering therapy and its associated factors among patients with type 2 diabetes mellitus in Malaysian primary care settings
2019
Author(s) : Hasniza Binti Zaman Huri Source :
Therapeutic and Clinical Risk Management
|
| 50. |
Pharmacist-led Academic Detailing Improves Statin Therapy Prescribing for Malaysian Patients with Type 2 Diabetes: Quasi-Experimental Design.
2019
Author(s) : Hasniza Binti Zaman Huri Source :
Plos One
|
| 51. |
Pharmacist-led academic detailing improves statin therapy prescribing for Malaysian patients with type 2 diabetes: Quasi-experimental design
2019
Author(s) : Hasniza Binti Zaman Huri Source :
PLOS ONE
|
| 52. |
Drug Related Problems in Patients with Rheumatoid Arthritis
2019
Author(s) : Hasniza Binti Zaman Huri Source :
Therapeutic and Clinical Risk Management
|
| 53. |
Drug-related problems in patients with rheumatoid arthritis
2019
Author(s) : Hasniza Binti Zaman Huri Source :
THERAPEUTICS AND CLINICAL RISK MANAGEMENT
|
| 54. |
Effectiveness and prescription pattern of lipid-lowering therapy and its associated factors among patients with type 2 diabetes mellitus in Malaysian primary care settings
2019
Author(s) : Hasniza Binti Zaman Huri Source :
THERAPEUTICS AND CLINICAL RISK MANAGEMENT
|
| 55. |
Demographic, Clinical and Lifestyle Predictors for Severity of Erectile Dysfunction and Biomarkers level in Malaysian Patients
2018
Author(s) : Hasniza Binti Zaman Huri Source :
Brazilian Journal of Pharmaceutical Sciences
|
| 56. |
Impact of Educational Outreach Intervention on Enhancing Healthcare Providers Knowledge about Statin Therapy Prescribing in Malaysian Patients with Type 2 Diabetes Mellitus
2018
Author(s) : Hasniza Binti Zaman Huri Source :
Journal of Evaluation in Clinical Practice
|
| 57. |
Association of glycaemic control and progression of diabetic retinopathy in type 2 diabetes mellitus patients
2018
Author(s) : Hasniza Binti Zaman Huri Source :
Brazilian Journal of Pharmaceutical Sciences
|
| 58. |
The Use of Antidepressants for Physical and Psychological Symptoms in Cancer
2018
Author(s) : Hasniza Binti Zaman Huri, Ahmad Hatim Bin Sulaiman Source :
Current Dr
|
| 59. |
Reduced mitochondrial DNA content in lymphocytes is associated with insulin resistance and inflammation in patients with impaired fasting glucose
2018
Author(s) : Hasniza Binti Zaman Huri Source :
CLINICAL AND EXPERIMENTAL MEDICINE
|
| 60. |
Reduced mitochondrial DNA content in lymphocytes is associated with insulin resistance and inflammation in patients with impaired fasting glucose
2018
Author(s) : Hasniza Binti Zaman Huri Source :
Clinical and Experimental Medicine
|
| 61. |
Development of a strategic tool for shared decision-making in the use of antidepressants among patients with major depressive disorder
2018
Author(s) : Hasniza Binti Zaman Huri Source :
IJERPH
|
| 62. |
Glycemic effects of simvastatin: Where do we stand?
2018
Author(s) : Hasniza Binti Zaman Huri, Luqman Bin Ibrahim Source :
Brazilian Journal of Pharmaceutical Sciences
|
| 63. |
Attitude and Self-Medication practice on Antibiotic use amongst general public in Alor Setar, Kedah, Malaysia
2018
Author(s) : Hasniza Binti Zaman Huri Source :
Madridge J Pharm Res
|
| 64. |
Patterns of statin therapy prescribing among hospitalized patients with Type 2 diabetes mellitus in two Malaysian tertiary hospitals
2018
Author(s) : Hasniza Binti Zaman Huri Source :
Tropical Journal of Pharmaceutical Research
|
| 65. |
Statin therapy prescribing for patients with type 2 diabetes mellitus: A review of current evidence and challenges.
2017
Author(s) : Hasniza Binti Zaman Huri Source :
J Pharm Bioall Sci
|
| 66. |
Drug-related problems in patients with erectile dysfunctions and multiple co-morbidities
2017
Author(s) : Hasniza Binti Zaman Huri Source :
Therapeutics and Clinical Risk Management
|
| 67. |
Altered Circulating Concentrations Of Active Glucagon-Like Peptide (GLP-1) And Dipeptidyl Peptidase 4 (DPP4) In Obese Subjects And Their Association With Insulin Resistance
2017
Author(s) : Hasniza Binti Zaman Huri Source :
Clinical Biochemistry
|
| 68. |
Alterations of cultured myotubes and fasting plasma metabolite profiles related to mitochondrial dysfunction in Type 2 diabetes subjects
2017
Author(s) : Hasniza Binti Zaman Huri Source :
Free Radical Biology and Medicine
|
| 69. |
A Review of The Use of Mirtazapine in Cancer Patients
2017
Author(s) : Hasniza Binti Zaman Huri Source :
Malaysian Journal of Psychiatry
|
| 70. |
Chemokine like receptor- 1 (CMKLR-1) receptor: A Potential Therapeutic Target in Management of Chemerin Induced Type 2 Diabetes Mellitus and Cancer
2017
Source :
Current Pharmaceutical Design
|
| 71. |
Apoptotic induction and inhibition of NF- B signaling pathway in human prostatic cancer PC3 cells by natural compound 2,2 -oxybis (4-allyl-1-methoxybenzene), biseugenol B, from Litsea costalis : an in vitro study.
2017
Author(s) : Hasniza Binti Zaman Huri Source :
OncoTargets
|
| 72. |
Apoptotic induction and inhibition of NF- B signaling pathway in human prostatic cancer PC3 cells by natural Compound 2,2'-Oxybis (4-allyl-1-methoxybenzene), biseugenol B, from Litsea Costalis: an in vitro study
2016
Author(s) : Hasniza Binti Zaman Huri Source :
OncoTargets and Therapy
|
| 73. |
Potential of apoptotic pathway-targeted cancer therapeutic research: Where do we stand?
2016
Author(s) : Hasniza Binti Zaman Huri Source :
Cell Death Disease
|
| 74. |
Association of psychological factors, patients' knowledge and management among patients with erectile dysfunction.
2016
Author(s) : Raymond Mark, Azad Hassan Bin Abdul Razack, Hasniza Binti Zaman Huri Source :
Patient Preference And Adherence
DOI :
10.2147/PPA.S99544
|
| 75. |
Factors Associated with Hypoglycemia Episodes In Hospitalised Type 2 Diabetes Mellitus Patients
2016
Author(s) : Hasniza Binti Zaman Huri Source :
Tropical Journal of Pharmaceutical Research
|
| 76. |
Genetic markers predicting sulphonylurea treatment outcomes in Type 2 Diabetes patients: current evidence and challenges for clinical implementation
2016
Author(s) : Hasniza Binti Zaman Huri Source :
The Pharmacogenomics Journal
|
| 77. |
Genetic Polymorphisms Associated with Overweight and Obesity in Uncontrolled Type 2 Diabetes Mellitus.
2016
Author(s) : Hasniza Binti Zaman Huri Source :
Biomarkers in Medicine
|
| 78. |
Association of DPP4 Gene Polymorphisms with Type 2 Diabetes Mellitus in Malaysian subjects
2016
Author(s) : Hasniza Binti Zaman Huri Source :
PLoS One
|
| 79. |
Polyesters Based on Linoleic Acid for Biolubricant Basestocks: Low Temperature,Tribological and Rheological Properties.
2016
Author(s) : Hasniza Binti Zaman Huri Source :
Plos One
|
| 80. |
Clinical and genetic predictors of dipeptidyl peptidase-4 inhibitor treatment response in type 2 diabetes mellitus
2016
Author(s) : Hasniza Binti Zaman Huri Source :
Pharmacogenomics
|
| 81. |
Association of psychological factors, patients knowledge, and management among patients with erectile dysfunction
2016
Author(s) : Hasniza Binti Zaman Huri Source :
Patient Preference and Adherence
|
| 82. |
Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells.
2016
Author(s) : Hasniza Binti Zaman Huri Source :
Drug Design Development and Therapy
|
| 83. |
Association of rs5219 KCNJ11 Gene Polymorphism with Pancreatic Beta-Cell Function, Insulin Resistance, and Glycemic Control of Sulfonylurea-treated Malaysian Type 2 Diabetes Patients.
2016
Author(s) : Hasniza Binti Zaman Huri Source :
Diabetes
|
| 84. |
A Study on Cloning and Expression of HIV A Study on Cloning and Expression of HIVA Study on Cloning and Expression of HIV by Transient Transfection
2016
Author(s) : Hasniza Binti Zaman Huri Source :
Research Journal of Pharmaceutical, Biological and Chemical Sciences
|
| 85. |
Pathway Mechanism of Potential Genomic Markers of Dipeptidyl Peptidase-4 Inhibitor Treatment Response in Type 2 Diabetes
2015
Author(s) : Hasniza Binti Zaman Huri Source :
Public Health Genomics
|
| 86. |
Glycaemic Control and Antidiabetic Drugs in Type 2 Diabetes Mellitus Patients with Renal Complications
2015
Author(s) : Hasniza Binti Zaman Huri Source :
Drug Design Development and Therapy
|
| 87. |
A Review on Biologically Active N-Myristoylated HIV-1 Nef Protein
2015
Author(s) : Hasniza Binti Zaman Huri Source :
Asian Journal of Biochemistry
|
| 88. |
Mitochondrial Dysfunction as a Central Event for Mechanisms Underlying Insulin Resistance: The Roles of Long Chain Fatty Acids
2015
Author(s) : Hasniza Binti Zaman Huri Source :
Diabetes/Metabolism Research and Reviews
|
| 89. |
Impact of Single Nucleotide Polymorphisms(SNPs) of Type 2 Diabetes (T2D) Genes on Patients Response to Sulphonylurea Therapy
2015
Author(s) : Hasniza Binti Zaman Huri Source :
Public Health Genomics
|
| 90. |
Association between glycemic control and anti-diabetic drugs in type 2 diabetes mellitus patients with cardiovascular complications
2015
Author(s) : Hasniza Binti Zaman Huri Source :
Drug Design Development and Therapy
|
| 91. |
The Serum Level of Soluble CD26/Dipeptidyl Peptidase-IV in Type 2 Diabetes Mellitus and Its Association with Metabolic Syndrome and Therapy with Antidiabetic Agents in Malaysian Subjects
2015
Author(s) : Hasniza Binti Zaman Huri Source :
PLoS One
|
| 92. |
Glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with renal complications.
2015
Author(s) : Lim Lay Peng, Lim Soo Kun, Hasniza Binti Zaman Huri Source :
Drug design, development and therapy
|
| 93. |
Chronic Kidney Disease Screening Methods and Its Implication for Malaysia: An in Depth Review
2015
Author(s) : Hasniza Binti Zaman Huri Source :
Global Journal of Health Science
|
| 94. |
Antitumor Activity for Gold (III) Complex by High Content Screening Technique (HCS) and Cell Viability Assay
2015
Author(s) : Hasniza Binti Zaman Huri Source :
Asian Journal of Biochemistry
|
| 95. |
Metabolomics The Complementary Field in Systems Biology: A Review on Obesity and Type 2 Diabetes
2015
Author(s) : Hasniza Binti Zaman Huri Source :
Molecular Biosystems
|
| 96. |
JNK Signaling Pathways Is Required For Mitochondrial Dysfunction-Induced Insulin Resistance In WRL-68 Human Liver Cell
2015
Author(s) : Hasniza Binti Zaman Huri Source :
Diabetes Technology & Therapeutics
|
| 97. |
Association of Genetic Polymorphisms of Dipeptidyl Peptidase-4 with Metabolic Syndrome Parameters in Malaysian Subjects. Public Health Genomics
2015
Author(s) : Hasniza Binti Zaman Huri Source :
Public Health Genomics
|
| 98. |
Celastrol Protects Against Antimycin A-induced Insulin Resistance in Human Skeletal Muscle Cells
2015
Author(s) : Hasniza Binti Zaman Huri Source :
Molecules
|
| 99. |
Metabolomics - the complementary field in systems biology: a review on obesity and type 2 diabetes
2015
Author(s) : Hasniza Binti Zaman Huri Source :
MOLECULAR BIOSYSTEMS
|
| 100. |
Sliding-scale versus basal-bolus insulin in the management of severe or acute hyperglycemia in type 2 diabetes patients: A retrospective study.
2014
Author(s) : Hasniza Binti Zaman Huri Source :
Plos One
|
| 101. |
Studies of the impact of occupational exposure on pharmaceutical workers to the development of antimicrobial drug resistance.
2014
Author(s) : Hasniza Binti Zaman Huri |
| 102. |
Drug-Related Problems in Patients with Benign Prostatic Hyperplasia: A Cross Sectional Retrospective Study
2014
Author(s) : Hasniza Binti Zaman Huri Source :
Plos One
|
| 103. |
Factors Associated with Treatment Response to Antidiabetic Agents in Compliant Type 2 Diabetes Mellitus Patients: A Brief Summary of 5-Year Data
2014
Author(s) : Hasniza Binti Zaman Huri Source :
Tropical Journal of Pharmaceutical Research
|
| 104. |
Drug-Related Problems in Patients with Benign Prostatic Hyperplasia: A Cross Sectional Retrospective Study
2014
Author(s) : Hasniza Binti Zaman Huri Source :
Plos One
|
| 105. |
Pancreatic gene variants potentially associated with dipeptidyl peptidase-4 inhibitor treatment response in Type 2 diabetes
2014
Author(s) : Shireene Ratna A/p D B Vethakkan, Hasniza Binti Zaman Huri Source :
Pharmacogenomics
|
| 106. |
Pancreatic gene variants potentially associated with dipeptidyl peptidase-4 inhibitor treatment response in Type 2 Diabetes
2014
Author(s) : Hasniza Binti Zaman Huri Source :
Pharmacogenomics
|
| 107. |
Amelioration of Mitochondrial Dysfunction-Induced Insulin Resistance in Differentiated 3T3-L1 Adipocytes via Inhibition of NF-kappa B Pathways
2014
Author(s) : Hasniza Binti Zaman Huri Source :
International Journal of Molecular Sciences
|
| 108. |
Factors Associated With Treatment Response To Antidiabetic Agents In Compliant Type 2 Diabetes Mellitus Patients: A Brief Summary Of 5 Years'Data
2014
Author(s) : Hasniza Binti Zaman Huri |
| 109. |
Pancreatic gene variants potentially associated with dipeptidyl peptidase-4 inhibitor treatment response in Type 2 diabetes
2014
Author(s) : Hasniza Binti Zaman Huri Source :
Pharmacogenomics
|
| 110. |
Effect of Interaction between Polymorphisms in the Insulin Receptor Substrate Genes in Type 2 Diabetes Mellitus Patients with Severe/Acute Hyperglycemia.
2014
Author(s) : Hasniza Binti Zaman Huri |
| 111. |
A Prospective Cohort Study of IRS Genes Polymorphisms in Type 2 Diabetes Mellitus Patients during Severe/Acute Hyperglycemia Phase: Part 1: Association with Insulin Resistance
2014
Author(s) : Hasniza Binti Zaman Huri Source :
Tropical Journal of Pharmaceutical Research
|
| 112. |
Oral drug treatments in patients with erectile dysfunction and multiple comorbidities: a retrospective observational study
2014
Author(s) : Azad Hassan Bin Abdul Razack, Hasniza Binti Zaman Huri Source :
Bmj Open
|
| 113. |
Studies of the Impact of Occupational Exposure of Pharmaceutical Workers on the Development of Antimicrobial Drug Resistance
2014
Author(s) : Hasniza Binti Zaman Huri Source :
Journal of Occupational Health
|
| 114. |
Factors Associated with Utilization of Dipeptidyl- 4 Inhibitors in Patients with Type 2 Diabetes Mellitus: A Cross-sectional Retrospective Study
2014
Author(s) : Hasniza Binti Zaman Huri Source :
International Journal of Endocrinology
|
| 115. |
Sliding-scale versus basal-bolus insulin in the management of severe or acute hyperglycemia in type 2 diabetes patients: A retrospective study.
2014
Author(s) : Hasniza Binti Zaman Huri |
| 116. |
A Prospective Cohort Study of IRS Genes Polymorphisms in Type 2 Diabetes Mellitus Patients during Severe/Acute Hyperglycemia Phase: Part 2: Association with Glycemic Control.
2014
Author(s) : Hasniza Binti Zaman Huri |
| 117. |
Amelioration of Mitochondrial Dysfunction-induced Insulin Resistance in Differentiated 3T3-L1 Adipocytes via Inhibition of NF-κB Pathways
2014
Author(s) : Hasniza Binti Zaman Huri Source :
International Journal of Molecular Sciences
|
| 118. |
Drug-Related Problems in Patients with Benign Prostatic Hyperplasia: A Cross Sectional Retrospective Study
2014
Author(s) : Hasniza Binti Zaman Huri Source :
PLOS ONE
|
| 119. |
Potential biomarkers for insulin resistance and atherosclerosis among type 2 diabetes mellitus patients with coronary artery disease
2014
|
| 120. |
Palm Olein as Renewable Raw Materials for Industrial and Pharmaceutical Products Applications: Chemical Characterization and Physicochemical Properties Studies
2014
Author(s) : Hasniza Binti Zaman Huri Source :
Advances in Materials Science and Engineering
|
| 121. |
Oral Drug Treatments in Subjects with Erectile Dysfunction and Multiple Comorbidities
2014
Author(s) : Rozalina Binti Zakaria, Sulaiman Wadi Harun Source :
Bmj Open
|
| 122. |
Sliding-Scale versus Basal-Bolus Insulin in the Management of Severe or Acute Hyperglycemia in Type 2 Diabetes Patients: A Retrospective Study
2014
Author(s) : Shireene Ratna A/p D B Vethakkan, Hasniza Binti Zaman Huri Source :
Plos One
|
| 123. |
Management of severe/acute hyperglycemia in hospitalised type 2 diabetes mellitus patients
2013
Author(s) : Hasniza Binti Zaman Huri |
| 124. |
Demographic and Clinical Predictors for Insulin Resistance in Type 2 Diabetes Mellitus Patients During Severe/Acute Hyperglycemia Phase.
2013
Author(s) : Hasniza Binti Zaman Huri |
| 125. |
Drug related problems in type 2 diabetes patients with hypertension: a cross-sectional retrospective study
2013
Author(s) : Hasniza Binti Zaman Huri Source :
Bmc Endocrine Disorders
|
| 126. |
Drug-related problems in type 2 diabetes mellitus patients with dyslipidemia
2013
Author(s) : Hasniza Binti Zaman Huri Source :
Bmc Public Health
|
| 127. |
Drug-Related Problems in Type 2 Diabetes Mellitus Patients with Dyslipidemia.
2013
Author(s) : Hasniza Binti Zaman Huri Source :
BMC Public Health
|
| 128. |
Potential Biomarkers of Insulin Resistance and Atherosclerosis in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease
2013
Source :
International Journal of Endocrinology
|
| 129. |
Drug Related Problems in Type 2 Diabetes Patients
With
Hypertension: A Cross-Sectional Retrospective
Study.
2013
Author(s) : Hasniza Binti Zaman Huri Source :
BMC Endocrine Disorders
|
| 130. |
Potential biomarkers of insulin resistance and atherosclerosis in type 2 diabetes mellitus patients with coronary artery disease
2013
Author(s) : Hasniza Binti Zaman Huri |
| 131. |
Drug related problems in type 2 diabetes patients with hypertension: a cross-sectional retrospective study
2013
Author(s) : Hasniza Binti Zaman Huri Source :
Bmc Endocrine Disorders
|
| 132. |
Optimisation of glycaemic control during episodes
of
severe/acute hyperglycaemia in patients with type
2
diabetes mellitus.
2012
Author(s) : Hasniza Binti Zaman Huri Source :
International Journal of Clinical Pharmacy
|
| 133. |
Demographic and Clinical Predictors for Insulin Resistance in Type 2 Diabetes Mellitus Patients During Severe/Acute Hyperglycemia Phase.
2012
Author(s) : Hasniza Binti Zaman Huri |
| 134. |
Factors influencing prescribing of different types of sulphonylureas amongst type 2 diabetes patients.
2010
Author(s) : Hasniza Binti Zaman Huri |
| 135. |
Factors influencing utilization of different types of sulphonylureas amongst type 2 diabetes patients
2010
Source :
Latin American Journal of Pharmacy
|
| 136. |
Factors Influencing Utilization of Different Types of Sulphonylureas Amongst Type 2 Diabetes Patients
2010
Source :
Latin American Journal of Pharmacy
|
| 137. |
A survey amongst Complementary Alternative Medicine (CAM) users with type 2 diabetes
2009
Author(s) : Rokiah Binti Pendek, Riyanto Teguh Widodo, Samsinah Binti Hussain, Hasniza Binti Zaman Huri Source :
International Journal of Diabetes and Metabolism
|
| 138. |
Comparison of diabetic ketoacidosis between type I and type II diabetics in Malaysia
2009
Author(s) : Hasniza Binti Zaman Huri |
| 139. |
Different characteristics of diabetic ketoacidosis between type 1 and type 2 diabetes patients in Malaysia
2009
Source :
Asian Biomedicine
|
| 140. |
A survey amongst Complementary Alternative Medicine (CAM) users with type 2 diabetes.
2009
Author(s) : Hasniza Binti Zaman Huri |
| 141. |
Use of antiplatelet agents for primary and secondary prevention of cardiovascular disease amongst type 2 diabetic patients
2008
Author(s) : Rokiah Binti Pendek, Hasniza Binti Zaman Huri Source :
Journal of Pharmacy Practice
|
| 142. |
Utilization of antiplatelet agents for primary and secondary prevention of cardiovascular disease amongst type 2 diabetics.
2008
Author(s) : Hasniza Binti Zaman Huri Source :
Journal of Pharmacy Practice
|
| 143. |
Self-Monitoring Blood Glucose (SMBG) in type 2 diabetics in Malaysia
2008
Author(s) : Hasniza Binti Zaman Huri |
| 144. |
Self-monitoring of blood glucose among type-2 diabetes patients in Malaysia
2008
Author(s) : Rokiah Binti Pendek, Hasniza Binti Zaman Huri Source :
Asian Biomedicine
|
| 145. |
Self-monitoring of blood glucose among type-2 diabetes patients in Malaysia
2008
Author(s) : Rokiah Binti Pendek, Hasniza Binti Zaman Huri Source :
Asian Biomedicine
|
| 146. |
Episodes of hypoglycemia and hyperglycemia during the use of sliding scale insulin in hospitalized diabetes patients
2007
Author(s) : Rokiah Binti Pendek, Hasniza Binti Zaman Huri Source :
Asian Biomedicine
|
| 147. |
Episodes of hypoglycemia and hyperglycemia during the use of sliding scale insulin in hospitalized diabetes patients
2007
Author(s) : Hasniza Binti Zaman Huri Source :
Asian Biomedicine
|
BOOK
| NO | DETAILS OF BOOK |
|---|---|
| 1. |
Utilisation of Variable Rate Intravenous Insulin Infusion
2017
Author(s) : Hasniza Binti Zaman Huri, Luqman Bin Ibrahim |
| 2. |
Hydrolysis, Separation and Purification of Fatty Acids for Bioproducts
2015
Author(s) : Hasniza Binti Zaman Huri |
| 3. |
Biolubricant Base Oil Synthesis and Its Application: Pharmaceutical and Industrial Applications Based on Enviromental Friendly
2015
Author(s) : Hasniza Binti Zaman Huri |
| 4. |
Training Manual for
Pharmacists for Management of Obesity and Overweight.
2012
Author(s) : Hasniza Binti Zaman Huri |
CHAPTER IN BOOK
| NO | DETAILS OF CHAPTER IN BOOK |
|---|---|
| 1. |
Dyslipidemia and Type 2 Diabetes Mellitus: Implications
and Role of Antiplatelet Agents in Primary Prevention
of Cardiovascular Disease
2012
Author(s) : Hasniza Binti Zaman Huri |
| 2. |
Dyslipidemia and type 2 diabetes mellitus:
Implications and role of antiplatelet agents in
primary prevention of cardiovascular diseases.
2011
Author(s) : Hasniza Binti Zaman Huri |
PROCEEDING
| NO | DETAILS OF PROCEEDING |
|---|---|
| 1. |
Pharmacy Programme and Clinical Pharmacy Teaching in the University of Malaya
2006
Author(s) : Hasniza Binti Zaman Huri |
RESEARCH PROJECT
| GRANT | PROGRESS | STATUS |
|---|---|---|
|
Targeting Lipogenic Pathway In T2dm Patients With Cardiovascular Disease: Unravelling The Cardio-protective Mechanism Of Sglt2-inhibitor On Epicardial Fat Thickness Via Multi-omics Approach
|
|
new |
|
"health Intervention Programme And Public Perception In The Management Of Non-communicable Diseases (ncds) In Community Pharmacy In Malaysia "
Researcher(s) : Associate Prof. Dr. Baharudin Bin Ibrahim |
|
on going |
|
Effect Of Slc22a1 Gene Polymorphisms On Glycemic Control And Metformin Intolerance In Type 2 Diabetes Patients At St Paul's Hospital And Zewuditu Memorial Hospital, Addis Ababa, Ethiopia
|
|
on going |
|
Pharmacokinetics-pharmacometabolomics Profiling Of Registered Andrographis Paniculata
|
|
end |
|
Pharmacokinetics-pharmacometabolomics Profiling Of Registered Andographis Paniculata
|
|
end |
|
A Phase 1 Clinical Trial On Healthy Volunteers To Assess The Clinical Safety Of Andrographis Paniculata
|
|
end |
|
A Phase 1 Clinical Trial On Healthy Volunteers To Assess The Clinical Safety Of Andrographis Paniculata
Researcher(s) : Tee Khim Boon |
|
end |
|
Pharmacokinetics Profile Of Andrographis Paniculata In Healthy Volunteer
Researcher(s) : Associate Prof. Dr. Alexander Tan Tong Boon, Associate Prof. Dr. Najihah Binti Mohd Hashim, Zaril Harza Zakaria, David Wishart |
|
end |
|
Genetic Polymorphisms Associated With Insulin Resistance And Atherosclerosis In Type 2 Diabetes Mellitus Patients With Coronary Artery Disease.
Researcher(s) : - |
|
end |
|
Association Of Clinical And Genetic Markers With Erythropoietin Deficiency Anemia And Erythropoietin Stimulating Agents Treatment Response In Pre-dialysis Chronic Kidney Disease
Researcher(s) : Prof. Dr. Lim Soo Kun |
|
end |
|
Clinical And Genetic Predictors For Sulphonylurea Response In Malaysian Type 2 Diabeted Patients
|
|
end |
|
CLINICAL AND GENETIC PREDICTORS FOR SULPHONYLUREA RESPONSE IN MALAYSIAN TYPE 2 DIABETES PATIENTS
Researcher(s) : - |
|
end |
|
Targeting The Human Prostate Cancer Stem Cells (pc3) Using Natural Compound From Litsea Costalis: A Novel Strategy To Overcome The Drug Resistant Aggresive Breast Tumors
Researcher(s) : - |
|
end |
|
Genetic Markers Of Oral Incretin-Based Therapy Response In Type 2 Diabetes Mellitus
Researcher(s) : - |
|
end |
|
Impact Of Pax4 Genes Mutation On Sitagliptin Treatment Response In Type 2 Diabetes Mellitus Patients
|
|
end |
|
Clinical And Genetic Markers Of The Dpp Iv Inhibitors Treatment Response In Type 2 Diabetes Mellitus Patients
Researcher(s) : Prof. Dr. Rokiah Binti Pendek |
|
end |
RESEARCH COLLABORATOR
| GRANT | PROGRESS | STATUS |
|---|---|---|
|
Transforming Breast Cancer Treatment with 3D?Needle Technology
Researcher(s) : Dr. Zarif Bin Mohamed Sofian, Prof. Dr. Hasniza Binti Zaman Huri, Dennis Douroumis |
|
new |
|
Unravelling the Pharmacogenetics of SGLT-2 Inhibitors: Towards Precision Medicine for Cardioprotection in Type 2 Diabetes Mellitus
Researcher(s) : Associate Prof. Dr. Baharudin Bin Ibrahim, Prof. Dr. Hasniza Binti Zaman Huri, Associate Prof. Dr. Ahmad Syadi Bin Mahmood Zuhdi, Tahir Bin Aris |
|
new |
|
Investigating In-vitro Neuroprotective Effects And In-vivo Pharmacokinetics Properties Of Intranasally Administered 3-(4-phenylbutoxy) Xanthone Lipid Nanocarriers.
Researcher(s) : Dr. Yow Hui Yin, Prof. Dr. Hasniza Binti Zaman Huri, Mah Siau Hui, Mohd Cairul Iqbal Bin Mohd Amin |
|
new |
|
Web-based Decision Aid For Pharmacological Management Major Depressive Disorder Patients: Feasibility And Efficacy Testing
Researcher(s) : Prof. Dr. Ng Chong Guan, Prof. Dr. Hasniza Binti Zaman Huri |
|
on going |
|
Perception, Adherence, Clinical, Economical And Health-related Quality Of Life Outcomes Of Careaide App Usage In Chronic Diseases
|
|
on going |
|
Investigating The Role Of Genetic Polymorphisms Of Ugt1a9 On Pharmacokinetics Of Mycophenolic Acid In Renal Transplant Patients_
Researcher(s) : Prof. Dr. Hasniza Binti Zaman Huri, Dr. Nusaibah Binti Abdul Rahim, Dr. Tee Ying Chew, Associate Prof. Dr. Ng Kok Peng, Dr. Janet Tan Sui Ling, Yu-wei Lin, Zullies Ikawati |
|
on going |
|
Enhancing Pediatric Care In Malaysia: Introducing The First Electronic Clinical Decision Support For Health Professional
Researcher(s) : Prof. Dr. Hasniza Binti Zaman Huri, Khairul Faizi Khalid, Tan Ching Hooi |
|
on going |
|
Open, Randomized, Parallel Group Study To Assess Efficacy, Safety, And Tolerability Of Repeat Doses Of Vaginal Hyaluronic Gel In Pre- And Post-menopausal Female.
Researcher(s) : Prof. Dr. Hasniza Binti Zaman Huri |
|
on going |
|
Graphene Based Human Breath Analyzing Sensors For Early Detaction Of Diabetes
Researcher(s) : Dr. Md. Arafat Mahmood, Prof. Dr. Hasniza Binti Zaman Huri, Prof. Dr. Muhammad Yazid Bin Jalaludin, Associate Prof. Dr. Shaifulazuar Bin Rozali, Dusan Losic |
|
end |
|
Metabolomics-driven Pharmaceutical Assessment Of Andrographis Paniculata (hempedu Bumi) As Antidiabetic Treatment
Researcher(s) : Dr. Mohd Zuwairi Bin Saiman, Prof. Dr. Hasniza Binti Zaman Huri, David Wishart |
|
end |
|
Investigating the role of miR-548m in epithelial-mesenchymal transition of cancer metastasis
Researcher(s) : Prof. Dr. Ivy Chung, Prof. Dr. Hasniza Binti Zaman Huri |
|
end |